Remifentanil-dexmedetomidine Anesthesia With a Caudal for Elective Surgery. (Remi-dex)

• Status: Withdrawn
• Trial end date: 2017-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This study intends to show the efficacy of remifentanil-dexmedetomidine infusions in combination with a caudal block for patients ages 1 year to 3 years old receiving elective surgery to investigate alternatives to the currently used volatile anesthetics.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Children's Research Institute; Mofya Diallo
• Treatments: Anesthetics; Dexmedetomidine; Remifentanil; Ropivacaine

Criteria

Inclusion Criteria:

• Children aged 1 - 3 years undergoing urologic surgery (circumcision, hydrocele repair, orchidopexy, mild hypospadias) or inguinal hernia repair

• American Society of Anesthesiologist Physical Status (ASA-PS) I or II

• Eligible for caudal block

• Parental/legal guardian consents for study '

Exclusion Criteria:

• Allergy to remifentanil, dexmedetomidine or ropivacaine

• Family history of malignant hyperthermia

• Parental/legal guardian refusal

• ASA-PS ≥ 3

• Symptoms of upper respiratory infection (URI) within the 2 weeks prior to surgery

• Known spinal deformity, presence of sacral dimple, or signs of infection at the site of the caudal block (e.g. diaper rash, skin redness or tenderness).